Meeting of the National Vaccine Advisory Committee, 52923 [2013-20797]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 166 / Tuesday, August 27, 2013 / Notices
technology/vendors.html, provides a
useful roadmap for developers to
review. It is a simple, web-based
checklist utilized by HHS officials to
allow vendors to document how their
products do or do not meet the various
Section 508 requirements.
No HHS, ONC, or other federal
government logo—The app must not use
HHS’, ONC’s, or any other federal
government agency’s logos or official
seals in the Submission, and must not
claim endorsement.
Functionality/Accuracy—A
Submission may be disqualified if the
software application fails to function as
expressed in the description provided
by the user, or if the software
application provides inaccurate or
incomplete information.
Security—Submissions must be free
of malware. Contestant agrees that ONC
may conduct testing on the app to
determine whether malware or other
security threats may be present. ONC
may disqualify the app if, in ONC’s
judgment, the app may damage
government or others’ equipment or
operating environment.
tkelley on DSK3SPTVN1PROD with NOTICES
Additional Information
General Conditions: ONC reserves the
right to cancel, suspend, and/or modify
the Contest, or any part of it, for any
reason, at ONC’s sole discretion.
Participation in this Contest constitutes
a contestant’s full and unconditional
agreement to abide by the Contest’s
Official Rules found at
www.challenge.gov.
Privacy Policy: ChallengePost collects
personal information from you when
you register on Challenge.gov. The
information collected is subject to the
ChallengePost privacy policy located at
www.challengepost.com/privacy.
Ownership of intellectual property is
determined by the following:
• Each entrant retains title and full
ownership in and to their submission.
Entrants expressly reserve all
intellectual property rights not
expressly granted under the challenge
agreement.
• By participating in the challenge,
each entrant hereby irrevocably grants
to Sponsor and Administrator a limited,
non-exclusive, royalty-free, worldwide
license and right to reproduce,
publically perform, publically display,
and use the Submission to the extent
necessary to administer the challenge,
and to publically perform and
publically display the Submission,
including, without limitation, for
advertising and promotional purposes
relating to the challenge.
Authority: 15 U.S.C. 3719.
VerDate Mar<15>2010
15:54 Aug 26, 2013
Jkt 229001
Dated: August 19, 2013.
David Muntz,
Principal Deputy National Coordinator for
Health Information Technology.
[FR Doc. 2013–20790 Filed 8–26–13; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Vaccine
Advisory Committee
Office of the Assistant
Secretary for Health, Office of the
Secretary, HHS.
ACTION: Notice of meeting.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that the National Vaccine Advisory
Committee (NVAC) will hold a meeting.
The meeting is open to the public. Preregistration is required for both public
attendance and comment. Individuals
who wish to attend the meeting and/or
participate in the public comment
session should register at https://
www.hhs.gov/nvpo/nvac, email nvpo@
hhs.gov, or call 202–690–5566 and
provide name, organization, and email
address.
SUMMARY:
The meeting will be held on
September 10–11, 2013. The meeting
times and agenda will be posted on the
NVAC Web site at https://www.hhs.gov/
nvpo/nvac as soon they become
available.
DATES:
U.S. Department of Health
and Human Services, Hubert H.
Humphrey Building, Room 800, 200
Independence Avenue SW.,
Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT:
National Vaccine Program Office, U.S.
Department of Health and Human
Services, Room 715–H, Hubert H.
Humphrey Building, 200 Independence
Avenue SW., Washington, DC 20201.
Phone: (202) 690–5566; Fax: (202) 690–
4631; email: nvpo@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to Section 2101 of the Public Health
Service Act (42 U.S.C. 300aa–1), the
Secretary of Health and Human Services
was mandated to establish the National
Vaccine Program to achieve optimal
prevention of human infectious diseases
through immunization and to achieve
optimal prevention against adverse
reactions to vaccines. The National
Vaccine Advisory Committee was
established to provide advice and make
recommendations to the Director of the
National Vaccine Program on matters
ADDRESSES:
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
52923
related to the Program’s responsibilities.
The Assistant Secretary for Health
serves as Director of the National
Vaccine Program.
The topics to be discussed at the
NVAC meeting will include updates
from the NVAC working groups on
Human Papillomavirus (HPV) Vaccine
and Maternal Immunization, Healthy
People 2020 Immunization objectives,
immunizations and the Affordable Care
Act, deliberation and vote on the NVAC
Report on Global Immunization and
NVAC Adult Immunization Standards
of Practice. The meeting agenda will be
posted on the NVAC Web site: https://
www.hhs.gov/nvpo/nvac prior to the
meeting.
Public attendance at the meeting is
limited to space available. Please note
agenda meeting times are approximate
and are subject to change. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
National Vaccine Program Office at the
address/phone listed above at least one
week prior to the meeting. Members of
the public will have the opportunity to
provide comments at the NVAC meeting
during the public comment periods on
the agenda. Individuals who would like
to submit written statements should
email or fax their comments to the
National Vaccine Program Office at least
five business days prior to the meeting.
Dated: August 20, 2013.
Bruce Gellin,
Director, National Vaccine Program Office,
Executive Secretary, National Vaccine
Advisory Committee.
[FR Doc. 2013–20797 Filed 8–26–13; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meetings of the National Biodefense
Science Board
Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services is hereby giving notice that the
National Biodefense Science Board
(NBSB) will be holding a public meeting
on September 12, 2013.
DATES: The September 12, 2013, NBSB
public meeting is tentatively scheduled
from 1:00 p.m. to 3:00 p.m. EST, both
in-person in Washington, DC and with
teleconference connectivity. The agenda
SUMMARY:
E:\FR\FM\27AUN1.SGM
27AUN1
]]>Agencies
[Federal Register Volume 78, Number 166 (Tuesday, August 27, 2013)]
[Notices]
[Page 52923]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-20797]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Vaccine Advisory Committee
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that the National Vaccine Advisory Committee (NVAC) will hold a
meeting. The meeting is open to the public. Pre-registration is
required for both public attendance and comment. Individuals who wish
to attend the meeting and/or participate in the public comment session
should register at https://www.hhs.gov/nvpo/nvac, email nvpo@hhs.gov, or
call 202-690-5566 and provide name, organization, and email address.
DATES: The meeting will be held on September 10-11, 2013. The meeting
times and agenda will be posted on the NVAC Web site at https://www.hhs.gov/nvpo/nvac as soon they become available.
ADDRESSES: U.S. Department of Health and Human Services, Hubert H.
Humphrey Building, Room 800, 200 Independence Avenue SW., Washington,
DC 20201.
FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S.
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone:
(202) 690-5566; Fax: (202) 690-4631; email: nvpo@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and
Human Services was mandated to establish the National Vaccine Program
to achieve optimal prevention of human infectious diseases through
immunization and to achieve optimal prevention against adverse
reactions to vaccines. The National Vaccine Advisory Committee was
established to provide advice and make recommendations to the Director
of the National Vaccine Program on matters related to the Program's
responsibilities. The Assistant Secretary for Health serves as Director
of the National Vaccine Program.
The topics to be discussed at the NVAC meeting will include updates
from the NVAC working groups on Human Papillomavirus (HPV) Vaccine and
Maternal Immunization, Healthy People 2020 Immunization objectives,
immunizations and the Affordable Care Act, deliberation and vote on the
NVAC Report on Global Immunization and NVAC Adult Immunization
Standards of Practice. The meeting agenda will be posted on the NVAC
Web site: https://www.hhs.gov/nvpo/nvac prior to the meeting.
Public attendance at the meeting is limited to space available.
Please note agenda meeting times are approximate and are subject to
change. Individuals who plan to attend and need special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify the National Vaccine Program Office at
the address/phone listed above at least one week prior to the meeting.
Members of the public will have the opportunity to provide comments at
the NVAC meeting during the public comment periods on the agenda.
Individuals who would like to submit written statements should email or
fax their comments to the National Vaccine Program Office at least five
business days prior to the meeting.
Dated: August 20, 2013.
Bruce Gellin,
Director, National Vaccine Program Office, Executive Secretary,
National Vaccine Advisory Committee.
[FR Doc. 2013-20797 Filed 8-26-13; 8:45 am]
BILLING CODE 4150-44-P
